You are here: Industry Insights > Diabetes

News List

Lupin gets tentative USFDA nod for empagliflozin and metformin hydrochloride ER tablets expresspharma
January 08, 2021
They are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus.
New process for producing synthetic insulin developed europeanpharmaceuticalreview
January 07, 2021
Researchers say that their novel way to produce synthetic insulin could also be used to create at least eight other drugs.
Glenmark launches Remogliflozin + Vildagliptin FDC in India to treat Type 2 diabetes expresspharma
December 30, 2020
The FDC will be marketed under two brand names Remo V and Remozen V priced at Rs 14 per tab and Rs 28 per day cost of therapy.
First Patient Dosed in Trial of Ultra-Concentrated Rapid Acting Insulin Candidate for Diabetes americanpharmaceuticalreview
December 17, 2020
Arecor Limited has announced dosing of the first patient in a Phase I clinical trial for its second clinical stage product, an ultra-concentrated rapid acting insulin, AT278.
Rise in sale of heart and diabetes drugs, immunity boosters in November: Pronto Consult survey expresspharma
December 17, 2020
The survey of over 3000 retailers across the country provides information about the consumer's buying pattern and preferences.
New research reveals impact of childhood type 1 diabetes on mental health pharmatimes
December 16, 2020
New research surveys released by medical device company Abbott have revealed the impact of childhood type 1 diabetes (T1D) on the emotional and mental health of children and their families in the UK.
Biocon Biologics signs MoU with CSSC in Tanzania for Mission 10 cents, affordable insulins programme expresspharma
December 16, 2020
Biocon Biologics, a subsidiary of Biocon, in continuation of its Mission 10 cents affordable insulins program for low- and middle-income countries (LMICs), has signed a Memorandum of Understanding (MoU) with the Christian Social Services Commission ...
Biocon Biologics, Mylan get CHMP recommendation for approval of biosimilar insulin Aspart expresspharma
December 14, 2020
Biocon Biologics (a subsidiary of Biocon), and Mylan (a subsidiary of Viatris) have received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommending approval of the market authorisation ..
Noncommunicable diseases are leading cause of death and disability worldwide, says WHO europeanpharmaceuticalreview
December 11, 2020
Alzheimer’s and diabetes enter the top ten global causes of death for the first time, while HIV/AIDS and tuberculosis deaths fall, according to the WHO’s 2019 Global Health Estimates.
Oramed Initiates Phase 3 Trial of Oral Insulin americanpharmaceuticalreview
December 11, 2020
Oramed Pharmaceuticals has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes (T2D).